Aa
Home
Entertainment
Sports
Politics
Fashion
Business
Health
Education
Financial
Home
>
financial

Plus Therapeutics (NASDAQ:CNSY) Stock Falls 4.1% - Should You Sell? - Ticker Report

Hein Phyo
Published on 2026-11-08 07:41:00
News Site
Plus Therapeutics (NASDAQ:CNSY) Stock Falls 4.1% - Should You Sell? - Ticker Report

Plus Therapeutics, Inc. ( NASDAQ:CNSY – Get Free Report )’s stock price traded down 4.1% during mid-day trading on Friday. The stock traded as low as $0.6001 and last traded at $0.6427. 508,717 shares changed hands during trading, an increase of 579% from the average daily volume of 74,870 shares. The stock had previously closed at $0.6699.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Zacks Research lowered Plus Therapeutics from a “hold” rating to a “strong sell” rating in a report on Wednesday, October 14th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Plus Therapeutics in a research note on Monday, November 2nd. Two equities research analysts have rated the stock with a Sell rating. According to MarketBeat, the company presently has a consensus rating of “Sell”.

Get Plus Therapeutics alerts:

Plus Therapeutics Stock Down 4.1%

The firm has a fifty day moving average price of $1.92. The stock has a market capitalization of $4.88 million, a PE ratio of -0.19 and a beta of 1.49.

Plus Therapeutics ( NASDAQ:CNSY – Get Free Report ) last issued its quarterly earnings data on Friday, August 14th. The company reported ($1...

Recommend

  • Copyright © Pubnews.online
  • Privacy Agreement
  • About us
English